Veerhealth Care revenue nearly doubles to ₹32.5 cr, but Q4 slips to a loss
A one-off ₹31 lakh charge turned the final quarter negative. For the full year, profit rose 39% on a 93% revenue jump.
— 2 earlier stories on Veerhealth Care Ltd. →What's new
- Annual revenue nearly doubled to ₹32.48 crores, up 93% from ₹16.87 crores.
- Q4 revenue of ₹16.76 crores was triple the year-ago quarter, but a ₹31 lakh exceptional charge pushed it to a net loss of ₹35.37 lakhs.
- Full-year net profit rose 39% to ₹54.40 lakhs; board skipped the dividend to conserve resources.
Why this matters
The results confirm the order wins from the past year are converting to revenue. The catch: profit margins remain paper-thin, and a single ₹31 lakh charge was enough to wipe out the entire final quarter. The no-dividend call is pragmatic for a nano-cap still burning cash on growth.
What we're watching
- Whether Q4's revenue momentum is sustained into the new fiscal year.
- How quickly the company can improve profitability as scale increases.
- The timing and size of the next dividend, if any.
The full read
Veerhealth Care's FY26 numbers tell a clear story: the order book is filling up, but the cash isn't there yet. Annual revenue more than doubled to ₹32.48 crores, a 93% jump from ₹16.87 crores, with Q4 alone delivering ₹16.76 crores. That's the kind of topline growth that explains why the market had already priced in the trend. The problem is profitability. Full-year net profit grew just 39% to ₹54.40 lakhs on that near-tripling of sales. In Q4, a single ₹31 lakh exceptional charge was enough to push the company into a net loss of ₹35.37 lakhs. The board skipped the dividend to keep cash in the business. For a nano-cap contract manufacturer still in the early innings of converting orders into scale, that's the right call. The unmodified audit opinion is a clean bill on the numbers, but the margins are razor-thin, and the next test is whether Veerhealth can convert revenue growth into real profit.
Questions answered
- Why did Veerhealth Care post a Q4 loss despite tripling its revenue?
- The company booked a one-off exceptional charge of ₹31 lakhs and a deferred tax provision in the quarter. The exceptional charge alone was enough to swing the quarter to a net loss of ₹35.37 lakhs.
- How much profit did Veerhealth make for the full year?
- Net profit for FY26 was ₹54.40 lakhs, up 39% from ₹39.1 lakhs in FY25. The profit growth was much slower than the 93% jump in revenue.
- Why isn't the company paying a dividend?
- The board cited a need to conserve resources. The company is a nano-cap contract manufacturer that needs cash to fund the growth driving its recent order wins.
- What drove the revenue surge?
- The growth came from a series of domestic and export orders won over the past twelve months. The Q4 revenue of ₹16.76 crores alone was nearly triple the prior-year quarter's.
Story so far
All notes on NIYATILEAS →- 30 May 2026 · 1:05 PM IST Veerhealth Care revenue nearly doubles to ₹32.5 cr, but Q4 slips to a loss
- today Veerhealth lands ₹3.6 cr face-care order from undisclosed FMCG client
- 15d ago Veerhealth Care's board meets to approve FY26 results and weigh a dividend